Kinstellar advises TEVA on $40.5bn acquisition of Allergan
Kinstellar has advised its client TEVA, the world’s largest generic drug company by sales, on the Hungarian and Bulgarian aspects of its $40.5bn global acquisition of Allergan Group. The deal combines two leading generics businesses with complementary strengths, particularly with respect to product pipelines and portfolios in these respective markets. The Kinstellar team was: Partner Anthony […]